HighTower Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,500
| Closed | -$39K | – | 3413 |
|
|
2023
Q2 | $39K | Buy |
+10,500
| New | +$39K | ﹤0.01% | 3140 |
|
|
2023
Q1 | – | Sell |
-32,500
| Closed | -$390K | – | 3226 |
|
|
2022
Q4 | $390K | Buy |
32,500
+496
| +2% | +$5.95K | ﹤0.01% | 2278 |
|
|
2022
Q3 | $206K | Buy |
32,004
+15,004
| +88% | +$96.6K | ﹤0.01% | 2572 |
|
|
2022
Q2 | $79K | Buy |
17,000
+3,000
| +21% | +$13.9K | ﹤0.01% | 2801 |
|
|
2022
Q1 | $121K | Hold |
14,000
| – | – | ﹤0.01% | 2920 |
|
|
2021
Q4 | $199K | Sell |
14,000
-14,000
| -50% | -$199K | ﹤0.01% | 2759 |
|
|
2021
Q3 | $616K | Sell |
28,000
-1,000
| -3% | -$22K | ﹤0.01% | 1931 |
|
|
2021
Q2 | $389K | Buy |
29,000
+5,000
| +21% | +$67.1K | ﹤0.01% | 2191 |
|
|
2021
Q1 | $243K | Buy |
24,000
+10,500
| +78% | +$106K | ﹤0.01% | 2442 |
|
|
2020
Q4 | $57K | Buy |
+13,500
| New | +$57K | ﹤0.01% | 2325 |
|